Tori N. Yamamoto

发表

Ionic immune suppression within the tumour microenvironment limits T cell effector function

W. Linehan, K. Okkenhaug, Jenny H. Pan, 2016, Nature.

Identification of essential genes for cancer immunotherapy

Feng Zhang, Neville E. Sanjana, Chi-Ping Day, 2017, Nature.

Test performance evaluation of SARS-CoV-2 serological assays

Aashish Manglik, Mark S. Anderson, Nevan J Krogan, 2020, Nature Biotechnology.

T cells genetically engineered to overcome death signaling enhance adoptive cancer immunotherapy

B. A. Aksoy, C. Klebanoff, J. Hammerbacher, 2019, The Journal of clinical investigation.

Inhibition of AKT signaling uncouples T cell differentiation from expansion for receptor-engineered adoptive immunotherapy.

C. Klebanoff, D. Stroncek, M. Kruhlak, 2017, JCI insight.

Memory T cell-driven differentiation of naive cells impairs adoptive immunotherapy.

F. Marincola, S. Rosenberg, P. Muranski, 2015, The Journal of clinical investigation.

Genome-wide profiling of druggable active tumor defense mechanisms to enhance cancer immunotherapy

Neville E. Sanjana, N. Sanjana, K. Wood, 2019, bioRxiv.

Host conditioning with IL-1β improves the antitumor function of adoptively transferred T cells

R. Germain, W. Paul, N. Restifo, 2019, The Journal of experimental medicine.

Novel Serial Positive Enrichment Technology Enables Clinical Multiparameter Cell Sorting

Christian Stemberger, M. Neuenhahn, D. Busch, 2012, PloS one.

CD137 Accurately Identifies and Enriches for Naturally Occurring Tumor-Reactive T Cells in Tumor

G. Coukos, D. Powell, Chunsheng Li, 2013, Clinical Cancer Research.

Identification of MAGE-C1 (CT-7) epitopes for T-cell therapy of multiple myeloma

D. Maloney, S. Riddell, D. R. Cook, 2011, Cancer Immunology, Immunotherapy.

Normalized Synergy Predicts That CD8 Co-Receptor Contribution to T Cell Receptor (TCR) and pMHC Binding Decreases As TCR Affinity Increases in Human Viral-Specific T Cells

C. Klebanoff, S. Eckhardt, Tori N. Yamamoto, 2017, Frontiers in immunology.

Generation of CD19-chimeric antigen receptor modiﬁed CD8 (cid:1) T cells derived from virus-speciﬁc central memory T cells

C. Turtle, S. Riddell, M. Jensen, 2011 .

Cancer genes disfavoring T cell immunity identified via integrated systems approach

Roxana A. Stefanescu, Neville E. Sanjana, N. Sanjana, 2022, Cell reports.

Mg 2+ regulation of kinase signaling and immune function

M. Lenardo, J. Cannons, P. Schwartzberg, 2019 .

Test performance evaluation of SARS-CoV-2 serological assays

Mark S. Anderson, Gregory M. Goldgof, C. T. Mowery, 2020, medRxiv.

Test performance evaluation of SARS-CoV-2 serological assays

Mark S. Anderson, Chun Jimmie Ye, Gregory M. Goldgof, 2020, Nature biotechnology.

Mg2+ regulation of kinase signaling and immune function

M. Lenardo, J. Cannons, P. Schwartzberg, 2019, The Journal of experimental medicine.

Developing neoantigen-targeted T cell–based treatments for solid tumors

N. Restifo, Tori N. Yamamoto, R. Kishton, 2019, Nature Medicine.

T cell stemness and dysfunction in tumors are triggered by a common mechanism

J. Locasale, C. Klebanoff, Jing Huang, 2019, Science.

PIRLs: a novel class of plant intracellular leucine-rich repeat proteins.

N. Forsthoefel, D. Vernon, Tori N. Yamamoto, 2005, Plant & cell physiology.

An engineered IL-2 partial agonist promotes CD8+ T cell stemness

K. Garcia, W. Leonard, Jangsuk Oh, 2021, Nature.

Cytomegalovirus-specific T cells are primed early after cord blood transplant but fail to control virus in vivo.

C. Turtle, S. Riddell, A. Guerrero, 2013, Blood.

Fas/CD95 prevents autoimmunity independently of lipid raft localization and efficient apoptosis induction

J. Lippincott-Schwartz, P. Sengupta, C. Klebanoff, 2016, Nature Communications.

31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part one

Charles J. Vaske, Rohan N. Borkar, Brian D. Kelly, 2016, Journal of Immunotherapy for Cancer.

The B-cell tumor-associated antigen ROR1 can be targeted with T cells modified to express a ROR1-specific chimeric antigen receptor.

Thomas M. Schmitt, B. Wood, D. Maloney, 2010, Blood.

Generation of CD19-chimeric antigen receptor modified CD8+ T cells derived from virus-specific central memory T cells.

C. Turtle, S. Riddell, M. Jensen, 2012, Blood.

Cross-presentation and genome-wide screening reveal candidate T cells antigens for a herpes simplex virus type 1 vaccine.

J. Haas, A. Wald, S. Bailer, 2012, The Journal of clinical investigation.

Multi-phenotype CRISPR-Cas9 Screen Identifies p38 Kinase as a Target for Adoptive Immunotherapies.

N. Restifo, D. Palmer, Li Jia, 2020, Cancer cell.

derived from virus-specific central memory T cells T cells + Generation of CD 19-chimeric antigen receptor modified CD 8

C. Turtle, S. Riddell, M. Jensen, 2011 .

Immunotherapy: Treatment of aggressive lymphomas with anti-CD19 CAR T cells

C. Klebanoff, N. Restifo, Tori N. Yamamoto, 2014, Nature Reviews Clinical Oncology.

Evaluation of SARS-CoV-2 serology assays reveals a range of test performance

Mark S. Anderson, Chun Jimmie Ye, Gregory M. Goldgof, 2020, Nature Biotechnology.

Cross-presentation and genome-wide screening reveal candidate T cells antigens for a herpes simplex virus type 1 vaccine.

J. Haas, A. Wald, S. Bailer, 2012, The Journal of clinical investigation.

CD137 Accurately Identifies and Enriches for Naturally Occurring Tumor-Reactive T Cells in Tumor

G. Coukos, Chunsheng Li, Qunrui Ye, 2013, Clinical Cancer Research.

Test performance evaluation of SARS-CoV-2 serological assays

Mark S. Anderson, Gregory M. Goldgof, P. Hsu, 2020, medRxiv.